Welwaze Medical, Inc.

Welwaze Medical, Inc. is a Miami-based medical device company specializing in women's breast healthcare solutions. The company develops advanced diagnostic tools focused on early breast disease detection through innovative thermal imaging technology. Their flagship product, Celbrea®, is a breast thermal activity indicator designed to detect elevated temperature as a thermal biomarker for potential early breast disease. Celbrea® is positioned as an adjunct to routine physical examination, including palpation, mammography, and other established breast disease detection procedures. The company emphasizes a human-first approach to healthcare technology, with a stated mission to develop advanced tools and devices that empower patients from all communities to improve their health. Welwaze Medical has received multiple industry recognitions, including the Florida Governor's 2018 Job Creation Award, Novartis Innovation Award 2018, and various entrepreneurial awards. The company operates from its headquarters in Doral, Florida, and maintains investor relations and corporate development functions. Welwaze positions itself at the intersection of humanity and technology, committed to developing medical devices that enhance health data collection, analysis, and accessibility for both patients and healthcare professionals.